Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma
Authors
Keywords
-
Journal
MOLECULAR PHARMACEUTICS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2022-10-28
DOI
10.1021/acs.molpharmaceut.2c00775
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dacarbazine-Loaded Targeted Polymeric Nanoparticles for Enhancing Malignant Melanoma Therapy
- (2022) Wei Xiong et al. Frontiers in Bioengineering and Biotechnology
- Managing Metastatic Melanoma in 2022: A Clinical Review
- (2022) Benjamin Switzer et al. JCO Oncology Practice
- Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy
- (2022) Jin-Qing Liu et al. JOURNAL OF CONTROLLED RELEASE
- Sonodynamic Therapy Using Dacarbazine-Loaded AuSiO2 Nanoparticles for Melanoma Treatment: An In-Vitro Study on the B16F10 Murine Melanoma Cell Line
- (2022) Arman Esmailzadeh et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Synthesis, Characterization, and In Vivo Cytokinome Profile of IL-12-Loaded PLGA Nanospheres
- (2022) Ryan A. Lacinski et al. Journal of Immunology Research
- Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
- (2022) Navid Sobhani et al. CANCER TREATMENT REVIEWS
- Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)
- (2021) Craig L Slingluff et al. Journal for ImmunoTherapy of Cancer
- Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma
- (2021) Sara Rhaissa Rezende do Reis et al. PHARMACEUTICAL RESEARCH
- Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
- (2021) Masahiro Ohara et al. Cancers
- Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation
- (2021) Yue Sun et al. Acta Biomaterialia
- Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma
- (2021) Dimitrios C. Ziogas et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Radiation therapy for uveal melanoma: a review of treatment methods available in 2021
- (2021) David A. Reichstein et al. CURRENT OPINION IN OPHTHALMOLOGY
- Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
- (2021) Amod A. Sarnaik et al. JOURNAL OF CLINICAL ONCOLOGY
- A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
- (2021) Surachet Imlimthan et al. Small
- Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review
- (2021) Luca Tagliaferri et al. Human Vaccines & Immunotherapeutics
- Multi-functional carboxymethyl chitin-based nanoparticles for modulation of tumor-associated macrophage polarity
- (2021) Yunfeng Wan et al. CARBOHYDRATE POLYMERS
- The Role of Melanoma Cell-Derived Exosomes (MTEX) and Photodynamic Therapy (PDT) within a Tumor Microenvironment
- (2021) Bridgette Mkhobongo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of radiotherapy and targeted therapy for melanoma brain metastases: a systematic review
- (2021) Yi Ge et al. MELANOMA RESEARCH
- Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
- (2021) Alejandro Garcia-Alvarez et al. OncoTargets and Therapy
- STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
- (2021) Takashi Nakamura et al. Journal for ImmunoTherapy of Cancer
- Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
- (2021) Claudia Trojaniello et al. Frontiers in Oncology
- IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
- (2021) Yingmei Luo et al. BIOMATERIALS
- The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
- (2021) Ryota Tanaka et al. Cancers
- RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
- (2021) Paula Colón-Bolea et al. Biomolecules
- Radiotherapy and immunotherapy in melanoma brain metastases
- (2021) Amir Anvari et al. Hematology/ Oncology and Stem Cell Therapy
- Melanoma: An update on systemic therapies
- (2021) Lauren Skudalski et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer
- (2021) Nan Hu et al. Molecular Therapy-Oncolytics
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Targeted melanoma radiotherapy using ultrasmall 177Lu-labeled α-melanocyte stimulating hormone-functionalized core-shell silica nanoparticles
- (2020) Xiuli Zhang et al. BIOMATERIALS
- Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
- (2020) Caiwen Huang et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- SMARCA family of genes
- (2020) Runjan Chetty et al. JOURNAL OF CLINICAL PATHOLOGY
- Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
- (2020) Qian Hu et al. Advanced Healthcare Materials
- Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma
- (2020) Chenyang Li et al. Nanoscale Research Letters
- Monocyte-derived multipotent cell delivered programmed therapeutics to reverse idiopathic pulmonary fibrosis
- (2020) Xin Chang et al. Science Advances
- Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
- (2020) Dejan Vidovic et al. Cancers
- Comparative Analysis of Au and Au@SiO2 Nanoparticle–Protein Interactions for Evaluation as Platforms in Theranostic Applications
- (2020) Derrick J. Swinton et al. ACS Omega
- Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery
- (2020) Antonio E. Barberio et al. ACS Nano
- WNT Signaling in Melanoma
- (2020) Anna Gajos-Michniewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MET-dependent solid tumours — molecular diagnosis and targeted therapy
- (2020) Robin Guo et al. Nature Reviews Clinical Oncology
- Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer
- (2020) Serkan Yaman et al. Frontiers in Bioengineering and Biotechnology
- Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
- (2020) Caroline Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
- (2020) Katie Hudson et al. Frontiers in Immunology
- Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review
- (2020) Junko Takahashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the ERK Signaling Pathway in Melanoma
- (2019) Paola Savoia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunotherapy of melanoma: facts and hopes
- (2019) Sarah A Weiss et al. CLINICAL CANCER RESEARCH
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Targeting ERK1/2 protein-serine/threonine kinases in human cancers
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma
- (2019) Harshita Mishra et al. Pharmaceutics
- Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma
- (2019) Luz Dary Gutiérrez-Castañeda et al. MELANOMA RESEARCH
- Current state of melanoma diagnosis and treatment
- (2019) Lauren E. Davis et al. CANCER BIOLOGY & THERAPY
- Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201)
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Boosting Interleukin‐12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR‐Tagged Nanogold
- (2019) Anna Maria Gasparri et al. Small
- EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma
- (2019) Yige Fu et al. Pharmaceutics
- Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis
- (2019) Daniela Cici et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melanoma pathology reporting and staging
- (2019) Richard A. Scolyer et al. MODERN PATHOLOGY
- Cholesterol‐conjugated PEGylated PAMAM as an Efficient Nanocarrier for Plasmid Encoding Interleukin‐12 Immunogene Delivery towards Colon Cancer Cells
- (2019) Elham Pishavar et al. BIOTECHNOLOGY PROGRESS
- Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
- (2019) Fatima Bikhezar et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver
- (2018) Jesus Vera-Aguilera et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Targeting Rac and Cdc42 GTPases in Cancer
- (2018) María del Mar Maldonado et al. CANCER RESEARCH
- High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
- (2018) Jose A. Guerrero-Martínez et al. Scientific Reports
- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
- (2018) Keunok Jung et al. OncoImmunology
- Propranolol for Off-label Treatment of Patients With Melanoma
- (2018) Vincenzo De Giorgi et al. JAMA Oncology
- The Evolution of Radiation Therapy in Treating Cancer
- (2018) Dorothy Abshire et al. Seminars in Oncology Nursing
- Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin
- (2018) Lili Zou et al. BIOMATERIALS
- SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
- (2018) Antoni Ribas et al. Cancer Discovery
- MEK inhibitors for the treatment of NRAS mutant melanoma
- (2018) Saro Sarkisian et al. Drug Design Development and Therapy
- Metformin: Focus on Melanoma
- (2018) Emilie Jaune et al. Frontiers in Endocrinology
- Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma
- (2018) Huijun Phoebe Tham et al. ACS Nano
- Structural snapshots of RAF kinase interactions
- (2018) Soheila Rezaei Adariani et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
- (2018) Hongli Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair
- (2018) Tsuyoshi Fukushima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HGF/c-MET Signaling in Melanocytes and Melanoma
- (2018) Malgorzata Czyz INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression
- (2018) Heydi Noriega-Guerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and characterization of a novel biocompatible pseudo-hexagonal NaCa-layered double metal hydroxides for smart pH-responsive drug release of dacarbazine and enhanced anticancer activity in malignant melanoma
- (2018) Hamid Asiabi et al. Materials Science & Engineering C-Materials for Biological Applications
- PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha
- (2017) May Wenche Jøraholmen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A compendium of ERK targets
- (2017) Evrim B. Ünal et al. FEBS LETTERS
- Role of Epigenetics in Uveal Melanoma
- (2017) Yongyun Li et al. International Journal of Biological Sciences
- COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
- (2017) Gerardo Botti et al. Journal of Translational Medicine
- The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
- (2017) Akinori Kawakami et al. LABORATORY INVESTIGATION
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
- (2017) Reinhard Dummer et al. LANCET ONCOLOGY
- KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
- (2017) Jonas Cicenas et al. MEDICAL ONCOLOGY
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- Current Development Status of MEK Inhibitors
- (2017) et al. MOLECULES
- Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling
- (2017) Andrew M. Kidger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy
- (2017) Siavash Raigani et al. Current Oncology Reports
- T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
- (2017) Daniela Schmid et al. Nature Communications
- TREX1 dictates the immune fate of irradiated cancer cells
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
- (2017) Camille Buffet et al. PLoS One
- HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment
- (2016) Stefan Hartmann et al. CLINICAL CANCER RESEARCH
- Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different origin
- (2016) A. Makowiecka et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
- (2016) Alex Kim et al. Expert Opinion on Drug Discovery
- Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy
- (2016) Jung Seok Kim et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
- (2016) Jeffrey S Weber et al. LANCET ONCOLOGY
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Tumor cell vascular mimicry: Novel targeting opportunity in melanoma
- (2016) Mary J.C. Hendrix et al. PHARMACOLOGY & THERAPEUTICS
- P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer
- (2016) Hira Lal Goel et al. Cell Reports
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Metastatic Melanoma – A Review of Current and Future Treatment Options
- (2015) E Maverakis et al. ACTA DERMATO-VENEREOLOGICA
- Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer
- (2015) Thu Oanh Dang et al. Expert Review of Anticancer Therapy
- Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
- (2015) Yu Sun et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
- (2015) Theofanis Floros et al. SEMINARS IN ONCOLOGY
- Immune-mediated adverse events of anticytotoxic T lymphocyte–associated antigen 4 antibody therapy in metastatic melanoma
- (2015) Shannon K. Quirk et al. Translational Research
- Nivolumab in melanoma: latest evidence and clinical potential
- (2015) Douglas B. Johnson et al. Therapeutic Advances in Medical Oncology
- Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
- (2015) Zeynep Eroglu et al. Therapeutic Advances in Medical Oncology
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- MiRNA in melanoma-derived exosomes
- (2014) Anna Gajos-Michniewicz et al. CANCER LETTERS
- Loss of JUNB/AP-1 promotes invasive prostate cancer
- (2014) M K Thomsen et al. CELL DEATH AND DIFFERENTIATION
- Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients
- (2014) M. S. Carlino et al. CLINICAL CANCER RESEARCH
- CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis
- (2014) Y.M. LUO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Simultaneous Inhibition of the HGF/MET and Erk1/2 Pathways Affect Uveal Melanoma Cell Growth and Migration
- (2014) Chandrani Chattopadhyay et al. PLoS One
- The Genesis of Tyrosine Phosphorylation
- (2014) T. Hunter Cold Spring Harbor Perspectives in Biology
- Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma
- (2014) C. E. Burd et al. Cancer Discovery
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- c-FOS suppresses ovarian cancer progression by changing adhesion
- (2013) L Oliveira-Ferrer et al. BRITISH JOURNAL OF CANCER
- Spontaneous regression of metastatic melanoma after inoculation with tetanus– diphtheria–pertussis vaccine
- (2013) T. Tran et al. Current Oncology
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
- (2013) H. K. Bid et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced Antitumor Response Mediated by the Codelivery of Paclitaxel and Adenoviral Vector Expressing IL-12
- (2013) Linjie Cao et al. MOLECULAR PHARMACEUTICS
- Regulation of Small GTPases by GEFs, GAPs, and GDIs
- (2013) Jacqueline Cherfils et al. PHYSIOLOGICAL REVIEWS
- NMR-based functional profiling of RASopathies and oncogenic RAS mutations
- (2013) M. J. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Forging a link between oncogenic signaling and immunosuppression in melanoma
- (2013) Jahan S. Khalili et al. OncoImmunology
- Melanoma Treatment Costs
- (2012) Gery P. Guy et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma
- (2012) K.T. Huynh et al. BRITISH JOURNAL OF DERMATOLOGY
- LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models
- (2012) S. Betty Yan et al. INVESTIGATIONAL NEW DRUGS
- Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations
- (2012) J. G. Greger et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
- (2012) T. M. Herndon et al. ONCOLOGIST
- Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
- (2012) Christine M. Lovly et al. PLoS One
- Preexisting MEK1 Exon 3 Mutations in V600E/K BRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors
- (2012) Hubing Shi et al. Cancer Discovery
- Dabrafenib and its potential for the treatment of metastatic melanoma
- (2012) Rajmohan Murali et al. Drug Design Development and Therapy
- Expression of the c-Met Proteins in Malignant Skin Cancers
- (2011) Yoon-Jin Lee et al. Annals of Dermatology
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modulation of Wnt/ -catenin signaling pathway by bioactive food components
- (2011) R. S. Tarapore et al. CARCINOGENESIS
- Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma
- (2011) Xiang-Yang Wang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
- (2011) Sergey I Nikolaev et al. NATURE GENETICS
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- In melanoma, beta-catenin is a suppressor of invasion
- (2011) I Arozarena et al. ONCOGENE
- Postoperative Radiotherapy in Head and Neck Mucosal Melanoma
- (2010) Adil Benlyazid et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center
- (2010) Mauricio A. Moreno et al. CANCER
- Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
- (2010) I. Kenessey et al. CURRENT CANCER DRUG TARGETS
- Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
- (2010) L. Grumolato et al. GENES & DEVELOPMENT
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- Integrating BRAF/MEK inhibitors into combination therapy for melanoma
- (2009) K S M Smalley et al. BRITISH JOURNAL OF CANCER
- Cellular radiosensitivity: How much better do we understand it?
- (2009) Penny Jeggo et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic engineering of a modified herpes simplex virus 1 vaccine vector
- (2009) XueQiao Liu et al. VACCINE
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search